Combined extraction of acyl carnitines and 26:0 lysophosphatidylcholine from dried blood spots: prospective newborn screening for X-linked adrenoleukodystrophy.

[1]  J. Boelens.  X-ALD: centralize care in an international network. , 2011, Blood.

[2]  J. Tolar,et al.  Early diagnosis of cerebral X-linked adrenoleukodystrophy in boys with Addison’s disease improves survival and neurological outcomes , 2011, European Journal of Pediatrics.

[3]  Jian Zeng,et al.  A rapid and sensitive protocol for prenatal molecular diagnosis of X-linked adrenoleukodystrophy. , 2010, Clinica chimica acta; international journal of clinical chemistry.

[4]  D. Chace,et al.  Comparison of amino acids and acylcarnitines assay methods used in newborn screening assays by tandem mass spectrometry. , 2010, Clinica chimica acta; international journal of clinical chemistry.

[5]  Zhenwen Zhao,et al.  An extremely simple method for extraction of lysophospholipids and phospholipids from blood samples , 2010, Journal of Lipid Research.

[6]  D. Matern,et al.  Acylcarnitine Analysis by Tandem Mass Spectrometry , 2010, Current protocols in human genetics.

[7]  A. Moser,et al.  Newborn screening for X-linked adrenoleukodystrophy (X-ALD): validation of a combined liquid chromatography-tandem mass spectrometric (LC-MS/MS) method. , 2009, Molecular genetics and metabolism.

[8]  G. Raymond,et al.  Essential fatty acid profiling for routine nutritional assessment unmasks adrenoleukodystrophy in an infant with isovaleric acidaemia , 2008, Journal of Inherited Metabolic Disease.

[9]  Piero Rinaldo,et al.  Acylcarnitine profile analysis , 2008, Genetics in Medicine.

[10]  M. Matsuo,et al.  Blood Lysophosphatidylcholine (LPC) Levels and Characteristic Molecular Species in Neonates: Prolonged Low Blood LPC Levels in Very Low Birth Weight Infants , 2007, Pediatric Research.

[11]  Hugo Moser,et al.  Combined liquid chromatography-tandem mass spectrometry as an analytical method for high throughput screening for X-linked adrenoleukodystrophy and other peroxisomal disorders: preliminary findings. , 2006, Molecular genetics and metabolism.

[12]  Donald H Chace,et al.  A biochemical perspective on the use of tandem mass spectrometry for newborn screening and clinical testing. , 2005, Clinical biochemistry.

[13]  G. Schmitz,et al.  High-throughput quantification of lysophosphatidylcholine by electrospray ionization tandem mass spectrometry. , 2002, Clinical chemistry.

[14]  J. Barton,et al.  Obesity and asthma are linked . . . really , 2002, Archives of disease in childhood.

[15]  H. Moser,et al.  Adrenoleukodystrophy: Incidence, new mutation rate, and results of extended family screening , 2001, Annals of neurology.

[16]  C. Vargas,et al.  X-linked adrenoleukodystrophy: clinical and laboratory findings in 15 Brazilian patients , 2000 .

[17]  D. Chace,et al.  Rapid diagnosis of MCAD deficiency: quantitative analysis of octanoylcarnitine and other acylcarnitines in newborn blood spots by tandem mass spectrometry. , 1997, Clinical chemistry.

[18]  A. Moser,et al.  Newborn Screening for Adrenoleukodystrophy , 2012, Molecular Diagnosis & Therapy.

[19]  Sandra Castillo,et al.  Liquid chromatography-mass spectrometry (LC-MS)-based lipidomics for studies of body fluids and tissues. , 2011, Methods in molecular biology.

[20]  A. Moser,et al.  Newborn screening for adrenoleukodystrophy: implications for therapy. , 2007, Molecular diagnosis & therapy.

[21]  An-Guor Wang,et al.  X-linked adrenoleukodystrophy , 1993, Clinical Neurology and Neurosurgery.